{"name": "Hydra Biosciences",
 "permalink": "hydra-biosciences",
 "crunchbase_url": "http://www.crunchbase.com/company/hydra-biosciences",
 "homepage_url": "http://www.hydrabiosciences.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2001,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@hydrabiosciences.com",
 "phone_number": "617-494-5230",
 "description": "Biopharmaceutical company",
 "created_at": "Sat Jun 13 05:07:43 UTC 2009",
 "updated_at": "Mon Apr 08 07:43:36 UTC 2013",
 "overview": "\u003Cp\u003EHydra Biosciences, a biopharmaceutical company based in Cambridge, Massachusetts, develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using its expertise in novel ion channels. Hydra\u0026#8217;s proprietary high throughput screening platforms enable the company to identify and develop drug candidates that address significant unmet medical needs.\u003C/p\u003E\n\n\u003Cp\u003EHydra\u0026#8217;s ion channel drug discovery program is currently focused on channels implicated in pain, inflammation and cardiovascular disease. Hydra\u0026#8217;s intellectual property portfolio, significant ion channel expertise, and flexible screening systems set it apart from other biopharmaceutical companies. Unlike classical sodium, calcium or potassium voltage-gated channels Hydra\u0026#8217;s novel ion channels provide the potential to develop selective and safer ion channel drugs.\u003C/p\u003E\n\n\u003Cp\u003EHydra has raised significant financing from blue chip investors since its inception. This prominent group of investors include: Abingworth Ventures, Advanced Technology Ventures, Polaris Ventures, Lilly Bio Ventures, New Enterprise Associates, BioVentures Investors, Biogen Idec, Boston Medical Investors, and MedImmune Ventures. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       40],
      "assets/images/resized/0004/8342/48342v1-max-150x150.png"],
     [[250,
       67],
      "assets/images/resized/0004/8342/48342v1-max-250x250.png"],
     [[264,
       71],
      "assets/images/resized/0004/8342/48342v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and Chief Executive Officer",
    "person":
     {"first_name": "Russell",
      "last_name": "Herndon",
      "permalink": "russell-herndon",
      "image":
       {"available_sizes":
         [[[81,
            108],
           "assets/images/resized/0004/8344/48344v1-max-150x150.jpg"],
          [[81,
            108],
           "assets/images/resized/0004/8344/48344v1-max-250x250.jpg"],
          [[81,
            108],
           "assets/images/resized/0004/8344/48344v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Chief Operating Officer and Executive Vice President of Development ",
    "person":
     {"first_name": "Glenn",
      "last_name": "Larsen",
      "permalink": "glenn-larsen",
      "image":
       {"available_sizes":
         [[[81,
            108],
           "assets/images/resized/0004/8346/48346v1-max-150x150.jpg"],
          [[81,
            108],
           "assets/images/resized/0004/8346/48346v1-max-250x250.jpg"],
          [[81,
            108],
           "assets/images/resized/0004/8346/48346v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Vice President of Finance and Treasurer",
    "person":
     {"first_name": "Tom",
      "last_name": "Burke",
      "permalink": "tom-burke",
      "image":
       {"available_sizes":
         [[[81,
            108],
           "assets/images/resized/0004/8347/48347v1-max-150x150.jpg"],
          [[81,
            108],
           "assets/images/resized/0004/8347/48347v1-max-250x250.jpg"],
          [[81,
            108],
           "assets/images/resized/0004/8347/48347v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Alan",
      "last_name": "Crane",
      "permalink": "alan-crane",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$22M",
 "funding_rounds":
  [{"round_code": "d",
    "source_url": "http://www.reuters.com/article/pressRelease/idUS118179+16-Jan-2009+BW20090116",
    "source_description": "Hydra Biosciences Raises $22 Million in Series D Financing",
    "raised_amount": 22000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 1,
    "funded_day": 16,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "MedImmune Ventures",
         "permalink": "medimmune-ventures",
         "image":
          {"available_sizes":
            [[[150,
               19],
              "assets/images/resized/0004/9449/49449v2-max-150x150.jpg"],
             [[250,
               31],
              "assets/images/resized/0004/9449/49449v2-max-250x250.jpg"],
             [[450,
               57],
              "assets/images/resized/0004/9449/49449v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "790 Memorial Drive, off Pleasant Street",
    "address2": "",
    "zip_code": "02139",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        98],
       "assets/images/resized/0004/8343/48343v1-max-150x150.jpg"],
      [[250,
        164],
       "assets/images/resized/0004/8343/48343v1-max-250x250.jpg"],
      [[450,
        296],
       "assets/images/resized/0004/8343/48343v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}